Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


Identified the genetic mutation of a rare neurological disease

The aneurysmal malformation of the Galen vein (MAVG) is a rare disease that affects the brain. Causes abnormalities in the circulatory system of the brain and can be fatal in newborns. A team of pediatric researchers and neurosurgeons collected a cohort of patients from the disease. In this way it was possible to identify the genetic mutations causing in the MAVG.

In the aneurysmal malformation of the vein of Galen the capillaries are missing between the arteries and the veins. These should act as a buffer between the first high pressure and the second low pressure. Their absence therefore increases the risk that the veins break. If the disease remains untreated, it is likely that the patient will die from massive hemorrhage. For this reason, early diagnosis is essential.

The researchers collected a group of people suffering from the disease. From the genetic analysis it was found that 30% of these had a mutated version of the EPHB4 gene. The mutation is part of a larger syndrome, which causes MAVG and spots on the skin present from birth. Some carriers of the mutation do not have the malformation, but they have the spots or develop them later. The reason is still unclear and will be deepened.

For the time being, the goal is to develop new diagnostic tools, also improving prenatal diagnosis. In fact, thanks to the discovery it will be possible to look for the EPHB4 gene and intervene before a vein breaks down. In addition, the team is developing inhibitors that affect the gene.

Source: yaledailynews.com

Link social

Link social